🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In the elderly, pharmacokinetics is altered. Gastric juice pH is elevated w...
Status
Completed
Location
BIOTRIAL
Start Date
2019-11-22
Trial ID
NCT04171752
Treatments Being Tested
The study was being conducted in order to assess the pharmacokinetics and t...
Status
Terminated
Location
University of California
Start Date
2019-06-25
Trial ID
NCT03883607
Treatments Being Tested
The enzyme responsible for the conversion of elafibranor into its active me...
Status
Completed
Location
Eurofins Optimed Clinical Pharmacology Unit
Start Date
2019-09-23
Trial ID
NCT03985969
Treatments Being Tested
This study is being conducted in order to assess the need for dose adjustme...
Status
Completed
Location
Eurofins Optimed
Start Date
2019-02-28
Trial ID
NCT03844555
Treatments Being Tested
The Sponsor, Genfit, has developed a new formulation of GFT505 (60 mg). The...
Status
Completed
Location
SGS Aster S.A.S. - Phase I Clinical Unit
Start Date
2011-11
Trial ID
NCT01474161
This study is being conducted in order to assess the need for dose adjustme...
Status
Completed
Location
Division of Clinical Pharmacology, University of Miami
Start Date
2018-12-12
Trial ID
NCT03765671
Treatments Being Tested
The primary objective of the study is to compare the effect of daily oral a...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2017-04-05
Trial ID
NCT03124108
Treatments Being Tested
This randomized, double-blind, cross-over (placebo or elafibranor \[GFT505\...
Status
Terminated
Location
NUTRIM School of Nutrition and Translational Research in Metabolism
Start Date
2019-08-16
Trial ID
NCT03953456
Treatments Being Tested
Abdominal obesity and type-2 Diabetes are associated with chronic liver dis...
Status
Completed
Location
Site 920
Start Date
2012-09
Trial ID
NCT01694849
Treatments Being Tested
The primary objectives of this study are to evaluate the effect of Elafibra...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2016-03
Trial ID
NCT02704403
Treatments Being Tested